Related Experiment Video
Updated: Jun 9, 2026
04:42
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
[Spinal cord stimulation - evidence and personal experience].
1DRK Kliniken Berlin, Klinik für Innere Medizin - Schwerpunkt Angiologie und kardiovaskuläre Frührehabilitation, Berlin, Deutschland. p.klein-weigel@web.de
Zentralblatt Fur Chirurgie
|September 1, 2010
Summary
Spinal cord stimulation (SCS) effectively treats chronic pain and critical limb ischemia (CLI). Measuring forefoot transcutaneous pO2 can predict SCS treatment success, potentially eliminating the need for trial stimulation.
Area of Science:
- Neuromodulation
- Vascular Medicine
- Pain Management
Context:
- Spinal cord stimulation (SCS) is a long-established therapy for chronic pain.
- SCS involves implanting an electrode in the epidural space to deliver electrical current to spinal roots.
- Beyond pain relief, SCS enhances local blood supply through sympatholytic effects and vasodilation.
Purpose:
- To evaluate the efficacy of SCS in critical limb ischemia (CLI).
- To explore the predictive value of forefoot transcutaneous pO2 measurements for SCS treatment success in CLI patients.
Summary:
- A Cochrane meta-analysis confirmed improved limb salvage rates with SCS in non-reconstructable CLI.
- Forefoot transcutaneous partial pressure of oxygen (pO2) measurements in different positions may predict SCS response.
- This predictive method could obviate the need for trial SCS in many CLI cases.
Impact:
- SCS offers a viable treatment option for critical limb ischemia, improving limb salvage.
- Transcutaneous pO2 assessment provides a non-invasive method to identify likely responders to SCS therapy.
- Optimizing patient selection for SCS can enhance treatment outcomes and resource utilization in vascular care.
